CS274600B2 - Method of pharmaceutical preparation that promotes wound healing - Google Patents

Method of pharmaceutical preparation that promotes wound healing

Info

Publication number
CS274600B2
CS274600B2 CS543688A CS543688A CS274600B2 CS 274600 B2 CS274600 B2 CS 274600B2 CS 543688 A CS543688 A CS 543688A CS 543688 A CS543688 A CS 543688A CS 274600 B2 CS274600 B2 CS 274600B2
Authority
CS
Czechoslovakia
Prior art keywords
wound healing
pharmaceutical preparation
promotes wound
promotes
pharmaceutical
Prior art date
Application number
CS543688A
Other languages
Czech (cs)
English (en)
Other versions
CS543688A2 (en
Inventor
Janos Dr Balint
Sandor Dr Jancso
Tamas Ing Farago
Janos Dr Erdei
Istvan Dr Kovacs
Zsuzsanna Dr Emri
Katalin Horvath
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of CS543688A2 publication Critical patent/CS543688A2/cs
Publication of CS274600B2 publication Critical patent/CS274600B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CS543688A 1987-08-04 1988-08-03 Method of pharmaceutical preparation that promotes wound healing CS274600B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (2)

Publication Number Publication Date
CS543688A2 CS543688A2 (en) 1990-10-12
CS274600B2 true CS274600B2 (en) 1991-08-13

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
CS543688A CS274600B2 (en) 1987-08-04 1988-08-03 Method of pharmaceutical preparation that promotes wound healing

Country Status (16)

Country Link
JP (1) JPH01117828A (de)
AU (1) AU612387B2 (de)
BE (1) BE1001932A4 (de)
BG (1) BG49522A1 (de)
CH (1) CH675833A5 (de)
CS (1) CS274600B2 (de)
DD (1) DD272414A5 (de)
DE (1) DE3826419A1 (de)
ES (1) ES2007544A6 (de)
FI (1) FI883638A (de)
FR (1) FR2619011A1 (de)
GB (1) GB2207865B (de)
HU (1) HU201683B (de)
IT (1) IT1226586B (de)
NL (1) NL8801930A (de)
SE (1) SE8802805L (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1241521B (it) * 1990-07-31 1994-01-17 Polifarma Spa Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
GB9424562D0 (en) 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (de) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Entbittertes Ranitidin-Präparat
TWI221768B (en) * 1996-08-16 2004-10-11 Schering Corp Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN103816560B (zh) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 一种用于创口修复的胶体液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
BE1001932A4 (fr) 1990-04-17
HUT47848A (en) 1989-04-28
IT8821634A0 (it) 1988-08-03
SE8802805L (sv) 1989-02-05
SE8802805D0 (sv) 1988-08-03
DD272414A5 (de) 1989-10-11
AU2038788A (en) 1989-02-09
HU201683B (en) 1990-12-28
FI883638A (fi) 1989-02-05
AU612387B2 (en) 1991-07-11
NL8801930A (nl) 1989-03-01
GB2207865B (en) 1991-10-09
BG49522A1 (en) 1991-12-16
GB2207865A (en) 1989-02-15
CH675833A5 (de) 1990-11-15
ES2007544A6 (es) 1989-06-16
JPH01117828A (ja) 1989-05-10
GB8818575D0 (en) 1988-09-07
FR2619011A1 (fr) 1989-02-10
DE3826419A1 (de) 1989-02-16
FI883638A0 (fi) 1988-08-03
CS543688A2 (en) 1990-10-12
IT1226586B (it) 1991-01-24

Similar Documents

Publication Publication Date Title
LV10624B (en) Method for preparation of azithromycine dihydrate
ZA889594B (en) Wound healing
GR890100314A (en) Process for the preparation of drug absorbates
GR880100512A (en) Preparation method of 4-ammonium derivatives of epipodophyllotoxinc glucosite
CS614388A2 (en) Method of pharmaceutical agent production
GB8704089D0 (en) Method of treatment
CS543688A2 (en) Method of pharmaceutical preparation that promotes wound healing
GB8828254D0 (en) Method of healing wounds in horses
IL87185A0 (en) Preparation of quinolonecarboxylic acids
EP0296483A3 (en) Preparation of ascorbic acid 6-esters
GB8712909D0 (en) Preparation of esters
CS708787A1 (en) Method of 5-azacytosines preparation
CS8806510A2 (en) Method of anilinofumarates preparation
CS435387A1 (en) Method of 3-phenylalkanales preparation
IL85487A0 (en) Preparation of alpha-cyanobenzyl esters
CS455287A1 (en) Method of reduced nicotinamidadenindinucleotide preparation
CS222287A1 (en) Method of 5-bromo-6-amino-1-methyluracil preparation
CS337587A1 (en) Method of 6-nitro-2-benzothiazolinone preparation
CS542387A1 (en) Method of 4-oxopentylalkanoates preparation
CS779787A1 (en) Method of 3-amino-4-chlorobenzamide preparation
CS346487A1 (en) Method of 6-bromo-2-benzothiazolinone preparation
CS542287A1 (en) Method of 5-hydroxy-2-pentanone preparation
CS706187A1 (en) Method of 5-hydroxy-2-pentanone preparation
CS788087A1 (en) Method of 5-bromo-6-amino-1-methyluracil preparation
CS955587A1 (en) Method of chlorofluoropropene preparation